GlassScriptPhysician profile
Ali Yassen
NPI 1528359296
$2,732.74
in general payments reported to CMS, 2019-2025
33 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,651 · 2020: $202 · 2022: $177 · 2023: $61.37 · 2024: $227 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $383.05 | 2019 | |
| Abiomed | $378.84 | 2019-2022 | |
| Abbott Laboratories | $265.01 | 2019-2023 | Jot Dx |
| Angiodynamics, INC. | $142.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $138.79 | 2019-2025 | |
| Cardiac Dimensions, INC. | $132.67 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.47 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $104.06 | 2025 | Cds - Mct/Cem Monitoring, Watchman Flx, Bodyguardian |
| Actelion Pharmaceuticals US, INC. | $84.28 | 2019 | |
| Sanofi-Aventis U.S. LLC | $81.50 | 2019 | |
| Amgen INC. | $79.02 | 2019-2020 | |
| Baxter Healthcare | $74.00 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $72.01 | 2019-2020 | |
| United Therapeutics Corporation | $56.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $55.08 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.08 | 2019 | |
| Inspire Medical Systems, INC. | $48.02 | 2024-2025 | Inspire |
| Philips North America LLC | $47.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $47.13 | 2019 | |
| Pfizer INC. | $45.93 | 2019-2024 | |
| Astellas Pharma US INC | $44.32 | 2019 | |
| Portola Pharmaceuticals, LLC | $40.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.03 | 2025 | Verquvo |
| Scpharmaceuticals INC. | $34.15 | 2025 | |
| Penumbra, INC. | $27.96 | 2025 | Indigo System |
| Amarin Pharma, INC. | $24.09 | 2019 | |
| Medtronic, INC. | $21.71 | 2024 | Symplicity G3 |
| Lilly USA, LLC | $20.43 | 2025 | Zepbound |
| E.R. Squibb & Sons, L.L.C. | $18.76 | 2025 | Camzyos |
| Ekos Corporation | $15.52 | 2019 | |
| Siemens Medical Solutions USA, INC. | $15.48 | 2023 | Artis Icono Floor |
| Irhythm Technologies, INC. | $14.46 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Yassen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.